HC Wainwright Brokers Lower Earnings Estimates for INKT
MiNK Therapeutics, Inc. (NASDAQ:INKT – Free Report) – Research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of MiNK Therapeutics in a report released on Thursday, May 15th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings per share of ($0.36) for the quarter, down from their […]
MiNK Therapeutics, Inc. (NASDAQ:INKT – Free Report) – Research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of MiNK Therapeutics in a report released on Thursday, May 15th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings per share of ($0.36) for the quarter, down from their […]
